Oxford Immunotec
AcquiredOxford Immunotec is a biotech company.
Oxford Immunotec is now Revvity
- Business Model
- B2B
- Website
- info.revvity.com
- Acquisition Date
- Jan 2021
About
Oxford Immunotec developed immunology diagnostics including the T-SPOT.TB test, which is now part of Revvity's portfolio of products and services. Revvity continues to support the established products while rolling out updated branding, and the local legal entities remain unchanged for the foreseeable future. In the United States, EUROIMMUN US exclusively provides and supports T-SPOT.TB, while Revvity continues its commitment to high-quality tuberculosis diagnostic solutions.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Jan 2021
Sign up to see all 3 events
Funding, valuations, and company events, with amounts and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oxford-immunotec"><img src="https://indexed.vc/api/badge/company/oxford-immunotec" alt="Oxford Immunotec on Indexed.vc" width="260" height="76" /></a>